304 results
8-K
EX-99.1
ATR
Aptargroup Inc.
25 Apr 24
Aptar Reports First Quarter 2024 Results
5:24pm
for proprietary drug delivery systems are expected to be within the 7-11% long-term target range for the year, after exceptionally strong double-digit growth … Liabilities
Total Current Liabilities
Long-Term Obligations
Deferred Liabilities and Other
Total Liabilities
AptarGroup, Inc. Stockholders' Equity
8-K
EX-99.1
iopl4xbanjnl fd
8 Feb 24
Aptar Reports Fourth Quarter and Annual 2023 Results
5:04pm
8-K
EX-99.1
f517mi0tpiqnfs6mjl
25 Oct 23
Aptar Reports Third Quarter 2023 Results
5:05pm
8-K
EX-99.1
l5ll2
27 Jul 23
Aptar Reports Second Quarter 2023 Results
5:07pm
S-8
EX-4.3
hswlr9y
4 May 23
Registration of securities for employees
5:26pm
8-K
EX-10.1
q3mh782ycu6d
4 May 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
oh099
28 Apr 23
Additional proxy soliciting materials
5:05pm
8-K
EX-99.1
4ve15
27 Apr 23
Aptar Reports First Quarter 2023 Results
5:02pm
8-K
6gwudj61yoan xn
13 Apr 23
Regulation FD Disclosure
9:41am
8-K
EX-99.1
5vb2akd5abv 2n6cl7
27 Oct 22
Aptar Reports Third Quarter 2022 Results
5:02pm